R. Nicholson

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

C Lovekin, A P Locker, JFR Robertson et al. · British Journal of Cancer · 1991 · 239 citations · Full text

Medicine, Molecular Biology, Oncology +14

ONCOPOOL – A European database for 16,944 cases of breast cancer

R.W. Blamey, B. Hornmark-Stenstam, Graham Ball et al. · European Journal of Cancer · 2009 · 116 citations

Medicine, Oncology, Surgery +13

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

DN Poller, C. E. Hutchings, M Galea et al. · British Journal of Cancer · 1992 · 96 citations · Full text

Medicine, Molecular Biology, Oncology +14

The long term prognostic significance of oestrogen receptor analysis in early carcinoma of the breast

John Winstanley, T Cooke, W.D. George et al. · British Journal of Cancer · 1991 · 34 citations · Full text

Medicine, Endocrinology, Oncology +16

The EGFR-selective tyrosine kinase inhibitor ZD1839 (‘Iressa’) is an effective inhibitor of tamoxifen-resistant breast cancer growth

JM Gee, Iain R. Hutcheson, Janice M. Knowlden et al. · European Journal of Cancer · 2001 · 20 citations

Medicine, Oncology, Pharmacology +12